227 related articles for article (PubMed ID: 15207615)
1. Influence of N-linked glycans on intracellular transport of hepatitis C virus E1 chimeric glycoprotein and its role in pseudotype virus infectivity.
Beyene A; Basu A; Meyer K; Ray R
Virology; 2004 Jul; 324(2):273-85. PubMed ID: 15207615
[TBL] [Abstract][Full Text] [Related]
2. Characterization of pseudotype VSV possessing HCV envelope proteins.
Matsuura Y; Tani H; Suzuki K; Kimura-Someya T; Suzuki R; Aizaki H; Ishii K; Moriishi K; Robison CS; Whitt MA; Miyamura T
Virology; 2001 Aug; 286(2):263-75. PubMed ID: 11485395
[TBL] [Abstract][Full Text] [Related]
3. Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells.
Meyer K; Basu A; Ray R
Virology; 2000 Oct; 276(1):214-26. PubMed ID: 11022009
[TBL] [Abstract][Full Text] [Related]
4. [Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins].
Goffard A; Lazrek M; Bocket L; Dewilde A; Hober D
Ann Biol Clin (Paris); 2007; 65(3):237-46. PubMed ID: 17502294
[TBL] [Abstract][Full Text] [Related]
5. Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus.
Lagging LM; Meyer K; Owens RJ; Ray R
J Virol; 1998 May; 72(5):3539-46. PubMed ID: 9557633
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus envelope glycoprotein E1 originates in the endoplasmic reticulum and requires cytoplasmic processing for presentation by class I MHC molecules.
Selby M; Erickson A; Dong C; Cooper S; Parham P; Houghton M; Walker CM
J Immunol; 1999 Jan; 162(2):669-76. PubMed ID: 9916684
[TBL] [Abstract][Full Text] [Related]
7. HCV E2 glycoprotein: mutagenesis of N-linked glycosylation sites and its effects on E2 expression and processing.
Slater-Handshy T; Droll DA; Fan X; Di Bisceglie AM; Chambers TJ
Virology; 2004 Feb; 319(1):36-48. PubMed ID: 14967486
[TBL] [Abstract][Full Text] [Related]
8. Efficient formation of vesicular stomatitis virus pseudotypes bearing the native forms of hepatitis C virus envelope proteins detected after sonication.
Tamura K; Oue A; Tanaka A; Shimizu N; Takagi H; Kato N; Morikawa A; Hoshino H
Microbes Infect; 2005 Jan; 7(1):29-40. PubMed ID: 15716060
[TBL] [Abstract][Full Text] [Related]
9. Deletion of N-glycosylation sites of hepatitis C virus envelope protein E1 enhances specific cellular and humoral immune responses.
Liu M; Chen H; Luo F; Li P; Pan Q; Xia B; Qi Z; Ho WZ; Zhang XL
Vaccine; 2007 Sep; 25(36):6572-80. PubMed ID: 17675185
[TBL] [Abstract][Full Text] [Related]
10. Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins.
Goffard A; Callens N; Bartosch B; Wychowski C; Cosset FL; Montpellier C; Dubuisson J
J Virol; 2005 Jul; 79(13):8400-9. PubMed ID: 15956584
[TBL] [Abstract][Full Text] [Related]
11. Coexpression of hepatitis C virus E1 and E2 chimeric envelope glycoproteins displays separable ligand sensitivity and increases pseudotype infectious titer.
Meyer K; Beyene A; Bowlin TL; Basu A; Ray R
J Virol; 2004 Dec; 78(23):12838-47. PubMed ID: 15542636
[TBL] [Abstract][Full Text] [Related]
12. Pseudotype hepatitis C virus enters immature myeloid dendritic cells through the interaction with lectin.
Kaimori A; Kanto T; Kwang Limn C; Komoda Y; Oki C; Inoue M; Miyatake H; Itose I; Sakakibara M; Yakushijin T; Takehara T; Matsuura Y; Hayashi N
Virology; 2004 Jun; 324(1):74-83. PubMed ID: 15183055
[TBL] [Abstract][Full Text] [Related]
13. Delineation of regions important for heteromeric association of hepatitis C virus E1 and E2.
Yi M; Nakamoto Y; Kaneko S; Yamashita T; Murakami S
Virology; 1997 Apr; 231(1):119-29. PubMed ID: 9143310
[TBL] [Abstract][Full Text] [Related]
14. Oligomerization of hepatitis C virus core protein is crucial for interaction with the cytoplasmic domain of E1 envelope protein.
Nakai K; Okamoto T; Kimura-Someya T; Ishii K; Lim CK; Tani H; Matsuo E; Abe T; Mori Y; Suzuki T; Miyamura T; Nunberg JH; Moriishi K; Matsuura Y
J Virol; 2006 Nov; 80(22):11265-73. PubMed ID: 16971440
[TBL] [Abstract][Full Text] [Related]
15. Mutations at two conserved acidic amino acids in the glycoprotein of vesicular stomatitis virus affect pH-dependent conformational changes and reduce the pH threshold for membrane fusion.
Fredericksen BL; Whitt MA
Virology; 1996 Mar; 217(1):49-57. PubMed ID: 8599235
[TBL] [Abstract][Full Text] [Related]
16. The two envelope membrane glycoproteins of Tomato spotted wilt virus show differences in lectin-binding properties and sensitivities to glycosidases.
Naidu RA; Ingle CJ; Deom CM; Sherwood JL
Virology; 2004 Feb; 319(1):107-17. PubMed ID: 14967492
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes.
Mazumdar B; Banerjee A; Meyer K; Ray R
Hepatology; 2011 Oct; 54(4):1149-56. PubMed ID: 21735466
[TBL] [Abstract][Full Text] [Related]
18. Neutralization of pseudotyped vesicular stomatitis virus expressing hepatitis C virus envelope glycoprotein 1 or 2 by serum from patients.
Lagging LM; Meyer K; Westin J; Wejstål R; Norkrans G; Lindh M; Ray R
J Infect Dis; 2002 Apr; 185(8):1165-9. PubMed ID: 11930327
[TBL] [Abstract][Full Text] [Related]
19. Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection.
Burioni R; Mancini N; Carletti S; Perotti M; Grieco A; Canducci F; Varaldo PE; Clementi M
Virology; 2004 Oct; 327(2):242-8. PubMed ID: 15351212
[TBL] [Abstract][Full Text] [Related]
20. The hypervariable region 1 of the E2 glycoprotein of hepatitis C virus binds to glycosaminoglycans, but this binding does not lead to infection in a pseudotype system.
Basu A; Beyene A; Meyer K; Ray R
J Virol; 2004 May; 78(9):4478-86. PubMed ID: 15078928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
